Maturational dyssynchrony in benign B-cell precursors following lymphocyte depleting chemotherapy: A potential pitfall for B-lymphoblastic leukemia minimal/measurable residual disease (MRD) flow cytometry analysis
Cytometry B Clin Cytom
.
2024 Mar;106(2):138-141.
doi: 10.1002/cyto.b.22161.
Epub 2024 Jan 21.
Authors
Alexander Placek
1
,
Brian Lockhart
2
,
Karin P Miller
1
3
,
Gerald B Wertheim
2
4
,
Shannon L Maude
5
6
,
Brent L Wood
1
3
,
Alexandra E Kovach
1
3
Affiliations
1
Hematopathology, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA.
2
Hematopathology, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
3
Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
4
Department of Pathology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
5
Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
6
Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
PMID:
38247200
DOI:
10.1002/cyto.b.22161
No abstract available
Publication types
Letter
MeSH terms
Flow Cytometry
Humans
Neoplasm, Residual
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*
Precursor Cells, B-Lymphoid